SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-027033
Filing Date
2022-09-28
Accepted
2022-09-28 16:16:29
Documents
75
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2595616
2 ex21.htm EX-21.1 3648
3 ex31-1.htm EX-31.1 11516
4 ex32-1.htm EX-32.1 8468
5 aud_001.jpg GRAPHIC 24205
  Complete submission text file 0001493152-22-027033.txt   12354106

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ppcb-20220630.xsd EX-101.SCH 82729
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ppcb-20220630_cal.xml EX-101.CAL 77047
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ppcb-20220630_def.xml EX-101.DEF 375959
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ppcb-20220630_lab.xml EX-101.LAB 644631
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ppcb-20220630_pre.xml EX-101.PRE 492125
69 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1767257
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-54878 | Film No.: 221276303
SIC: 2834 Pharmaceutical Preparations